IRIS
MARTORANA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.086
AS - Asia 1.233
EU - Europa 862
SA - Sud America 190
AF - Africa 154
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.528
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.053
IT - Italia 527
SG - Singapore 466
CN - Cina 434
BR - Brasile 170
KR - Corea 124
CI - Costa d'Avorio 112
IN - India 97
IE - Irlanda 87
FI - Finlandia 45
DE - Germania 41
SN - Senegal 27
VN - Vietnam 27
GB - Regno Unito 26
CA - Canada 20
CZ - Repubblica Ceca 19
PL - Polonia 19
NL - Olanda 17
BE - Belgio 16
JP - Giappone 15
RU - Federazione Russa 15
HK - Hong Kong 12
SE - Svezia 11
ES - Italia 10
AR - Argentina 9
BD - Bangladesh 9
MX - Messico 9
UA - Ucraina 9
NG - Nigeria 8
UZ - Uzbekistan 8
ID - Indonesia 6
IR - Iran 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
LT - Lituania 5
PK - Pakistan 5
IL - Israele 4
IQ - Iraq 4
TR - Turchia 4
ZA - Sudafrica 4
CH - Svizzera 3
CO - Colombia 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
EC - Ecuador 2
FR - Francia 2
LB - Libano 2
OM - Oman 2
PY - Paraguay 2
TN - Tunisia 2
BB - Barbados 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
MA - Marocco 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.528
Salva come PNG Salva come JPEG
Città #
Dallas 744
Santa Clara 343
Singapore 297
Hefei 237
Chicago 135
Catania 123
Seoul 123
Chandler 113
Abidjan 112
Los Angeles 94
Ashburn 86
Dublin 86
Kochi 80
Beijing 58
Boardman 49
New York 43
Palermo 33
Rome 30
Dakar 27
Civitanova Marche 23
Milan 22
Cambridge 21
São Paulo 21
Brno 19
Lawrence 19
Turku 19
Lappeenranta 18
Munich 18
Bari 16
Brussels 16
Warsaw 16
Andover 15
Tokyo 15
Council Bluffs 12
Hong Kong 12
San Giovanni la Punta 12
Brooklyn 11
Wilmington 10
Buffalo 9
Des Moines 9
Abuja 8
Bremen 8
Cosenza 8
Helsinki 8
Messina 8
Montreal 8
Naples 8
Santa Venerina 8
Seattle 8
Stockholm 8
Columbus 7
Grafing 7
Grammichele 7
Ho Chi Minh City 7
The Dalles 7
Aci Catena 6
Denver 6
Florence 6
San Francisco 6
Tashkent 6
Tehran 6
Chennai 5
Jacksonville 5
Orem 5
Atlanta 4
Belo Horizonte 4
Charlotte 4
Dong Ket 4
Hanoi 4
Johannesburg 4
London 4
Manchester 4
Mascalucia 4
Mexico City 4
Palagiano 4
Paternò 4
Phoenix 4
Toronto 4
Verona 4
Aci Castello 3
Bedford 3
Bengaluru 3
Brasília 3
Curitiba 3
Fantina 3
Houston 3
Jakarta 3
Modica 3
Nicolosi 3
Nola 3
Pescantina 3
Portland 3
Redondo Beach 3
Ribeirão Preto 3
Rio de Janeiro 3
Rometta 3
Saint Petersburg 3
Salvador 3
Tampa 3
Trecastagni 3
Totale 3.435
Salva come PNG Salva come JPEG
Nome #
148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy 202
Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis 178
Drivers of choice and outcomes of breast-conserving surgery versus mastectomy in breast cancer patients with complete response following neoadjuvant therapy: a retrospective analysis from the EUSOMA database 163
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 130
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 127
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily 126
Biomarkers and prognostic factors for malignant pleural mesothelioma 120
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 120
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 107
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 96
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 96
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature 95
Orbital metastasis from thyroid cancer: a case report and review of the literature 93
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 93
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 92
ENDOMETRIAL STROMAL TUMOR (SARCOMA) WITH LIMITED MIOMETRIAL INFILTRATION: A RARE CASE WITH PELVI-PERITONEAL METASTASES 92
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 90
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 86
Opportunities and challenges of liquid biopsy in thyroid cancer 86
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 84
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 84
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 81
A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors 81
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 76
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype 72
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 72
Efficacy of mitomycin C plus a fluoropyrimidine in pretreated patients with metastatic colorectal cancer eligible to regorafenib: Results of a retrospective study 71
Implications of antidepressants use in breast cancer: A brief review 70
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 69
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients 68
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 66
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases 66
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcoma 65
Type 2 diabetes and cancer: problems and suggestions for best patient management 62
More Than Meets the Eye: A Case of Breast Cancer Switching from Being Luminal-Androgen-Receptor-Positive to Being Hormone-Receptor-Positive 61
Nasopharyngeal Metastasis from Lung Adenocarcinoma: A Case Report and Literature Review 60
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 60
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer 59
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance 59
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 59
Profilo Molecolare in una Coorte di Neoplasie Tiroidee Insorte nell'Area Vulcanica della Sicilia 58
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 58
Efficacy of A Fluoropyrimidine plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: A Retrospective Study 58
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities 56
REThinking the role of the RET oncogene in breast cancer 55
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors 54
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 52
Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study 51
Prognostic value of the interval between the last neoadjuvant chemotherapy (CT) administration and breast surgery: Preliminary data of the NeoBracer international observational study 50
Everything Comes with a Price: The Toxicity Profile of DNA-Damage Response Targeting Agents 49
Unveiling Prostate-Specific Membrane Antigen’s Potential in Breast Cancer Management 49
Ribociclib efficacy in special populations and analysis of patient reported outcomes in the MONALEESA trials 47
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review 44
Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancer 43
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project 39
Phase I dose-escalation study of the dual PI3K-mTORC1/2 inhibitor gedatolisib in combination with paclitaxel and carboplatin in patients with advanced solid tumors 38
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer 37
Letter to the Editor: statistics and clinical perception of patients’ reported outcomes for palbociclib and abemaciclib: a sliding doors story 37
Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database 28
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directions 26
MTClin: Integrating MammaTyper® to predict neoadjuvant therapy response in HER2+ breast cancer 17
A systematic review of phase I trials in patients with ovarian cancer 11
Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancer 10
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 8
Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review 5
Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2– breast cancer patients: a retrospective study 5
Reply to: EUSOMA and NCCN should include clinical staging after neoadjuvant therapy as a quality indicator for treatment guidance 3
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer 2
Radiomics in cervical and endometrial cancer 2
Totale 4.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 6 3 2 3 12 0 3 10
2021/2022118 1 14 2 2 21 2 19 3 6 5 12 31
2022/2023429 24 23 21 50 20 60 13 83 85 7 25 18
2023/2024337 43 52 16 12 11 66 3 15 2 19 45 53
2024/20251.617 43 187 81 74 238 224 72 65 67 122 266 178
2025/20262.042 252 455 859 278 198 0 0 0 0 0 0 0
Totale 4.629